A Special Thanks to Our Sponsor

Day One Agenda
Tuesday, July 25 

*All times in Central Time

9:00   REGISTRATION & VIRTUAL SIGN IN

9:20   CHAIRPERSON’S OPENING REMARKS

9:30   KEYNOTE PANEL: BEYOND THE PANDEMIC: 2023 PERSPECTIVE ON THE POST-COVID ERA OF PRE-LAUNCH MEDICAL AFFAIRS
• Navigating the new hybrid model of medical affairs
• Advocating the value of medical affairs during pre-launch
• Developing mature business-acumen in medical affairs and MSL teams
Moderator:
Luca Dezzani, JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
Panelists:
Scott McConnell, VENATORX PHARMACEUTICALS
Nabil Chehab, ASTRAZENECA

10:45   VIRTUAL NETWORKING & COFFEE BREAK

11:15 –2:15   CASE STUDY SERIES: EFFECTIVE LAUNCH PLANNING PROCESSES ACROSS DIVERSE THERAPEUTIC AREAS
From developing a clear scientific message, to proactively engaging KOLs, and ensuring the commercial team is supported to market new therapeutics upon FDA approval, medical affairs teams play an essential role in ensuring launch excellence. With timely perspectives on vaccines and oncology, this two-part case study series will provide a glimpse at how medical affairs teams mobilize pre-launch activities throughout the product life cycle in preparation for a new product hitting the market.

11:15   PART I: VACCINES
Karita Ambrose, Senior Director, US Head Medical Affairs
CSL SEQIRUS

12:00   LUNCHEON BREAK

1:00   PART II: ONCOLOGY
Nabil Chehab, Lung Cancer Medical Franchise Head/Executive Medical Director-US Medical Affairs
ASTRAZENECA

1:45   VIRTUAL NETWORKING & COFFEE BREAK

2:00   SMALL GROUP DISCUSSIONS: ELEVATING CROSS-FUNCTIONAL COLLABORATION TO PROMOTE LAUNCH READINESS
• Pre-launch collaboration opportunities for optimal medical affairs value-add
• Best practices for gaining collaboration buy-in from internal stakeholders
        » Leadership
        » Clinical development
        » Product launch strategy group
• Overcoming internal silos and messaging misalignment between teams
Co-Facilitators:
Lynn Bass, Senior Director & Head, Medical Science Directors
MEDEXUS
Rohan Zaveri, Global Medical Affairs
TAKEDA

2:45   GLOBAL MEDICAL AFFAIRS ALIGNMENT & LOCALIZATION ACROSS COUNTRIES
• Efficiencies in localizing global medical affairs plans across countries
• Facilitating timely communication between global and in-country teams
• Establishing accountability and governance of deliverables
Deb Braccia, Head of Global Medical Affairs Excellence
KYOWA KIRIN

3:15   Closing Remarks & End of Day 1

Day Two Agenda
Wednesday, July 26

9:00   REGISTRATION & VIRTUAL SIGN IN

9:20   CHAIRPERSON’S OPENING REMARKS

9:30   PANEL DISCUSSION: OPTIMIZING PRE-LAUNCH KOL ACCESS & ENGAGEMENT
• Strategies to increase facetime for more meaningful KOL engagement
• Best practices and communication techniques for improving dialogue
• The role of emotional intelligence in internal and external engagement
• Pre-launch specific training initiatives for new MSLs and field teams
Moderator:
Tom Caravela, THE CAROLAN GROUP, MSL TALK PODCAST
Panelists:
Peter Goldberg, UCB
Scott McConnell, VENATORX PHARMACEUTICALS
Gigi Shafai, PEAR THERAPEUTICS

10:15   INTERACTIVE WORKSHOP: DEVELOPING DATA STORYTELLING SKILLS TO PREPARE THE PRE-LAUNCH LANDSCAPE
Developing and staying aligned with a clear pre-launch scientific message is an essential piece of engineering a robust medical affairs work stream. In this interactive workshop, attendees will hear more on the importance of data storytelling and the need to drive scientific acumen alongside communication skills. Attendees will then take part in some short exercises to experience some of the many tools that can be used to maximize engagement with training and enhance field medical effectiveness.
Jill Fenwick, Director, Global Medical Training, Oncology
EMD SERONO

11:00   VIRTUAL NETWORKING & COFFEE BREAK

11:30   FIRESIDE CHAT: 2023 OUTLOOK ON THE IMPACT OF THE EVOLVING PAYER LANDSCAPE ON MEDICAL AFFAIRS
• Market access considerations for early launch planning success
• Payer expectations for generating evidence and meeting patient needs
• Navigating the collaboration preferences of payers and benefit managers
Mark Hiatt, RADSITE
Eugean Jiwanmall, INDEPENDENCE BLUE CROSS

12:15   LUNCHEON BREAK

1:15   ENGINEERING MEANINGFUL EVIDENCE GENERATION PLANS TO SUPPORT LAUNCH READINESS
• Cross-functional collaboration opportunities for optimal planning
          » Medical affairs
          » Clinical development
          » HEOR
• Expanding clinical development into integrated evidence generation plan
• Establishing a comprehensive integrated generation planning process
Tao Wu, Clinical, Scientific & Medical Affairs Lead
PHILIPS

2:00   MID-SIZE COMPANY PERSPECTIVE: BUILDING EFFECTIVE MEDICAL AFFAIRS TEAMS FOR LAUNCH READINESS
• Creating an enterprise-level leadership model with executive sponsorship
• Effectively scaling launch-planning capabilities with limited resources
• Considering launch scenarios and alignment around product value narratives
• Fostering external value creation to raise importance of medical launch readiness
Stacey Versavel, Senior Director Medical Affairs
CEREVEL THERAPEUTICS

2:45   LEGAL PERSPECTIVE: OVERCOMING COMPLIANCE HURDLES WITH HCP DIGITAL
ENGAGEMENT
• 2023 medical affairs update on legal landscape of digital engagement
• Challenges and opportunities for digital HCP medical information delivery
• Regulatory considerations for building a multi-channel engagement strategy
Monica Chmielewski, Partner
FOLEY & LARDNER LLP

3:30   Closing Remarks & Conference Conclusion

Who should attend:

Executives that will find this program of greatest relevance are those currently working to ensure launch success. Job titles of those executives that will find this program to be most applicable to the job function include:
• Medical Affairs
• Medical Directors
• Medical Science Liaisons
• Publication Directors
• Clinical Affairs
• Field Medical Affairs